Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
With
Ospedali Riuniti di Foggia
This clinical trial is a multi-center, randomized, controlled, open label, pilot study, lasting 6 months.
A target number of seventy individuals with hypertension meeting inclusion and exclusion criteria, assessed at enrollment, and which have signed the informed consent, will be recruited.
Age
50–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
arterial hypertension stage I-II
stable control of blood pressure
eGFR \> 60
informed consent signed
You may not be if
uncontrolled hypertension
therapy with diuretics
need for therapy with more than three antihypertensive drugs
proteinuria greater than 1 g/day
celiac disease
systemic inflammatory diseases
suspicion or clinical diagnosis of malignancy
chronic liver disease
treatment with corticosteroids or immunosuppressive drugs
